Lynn Gold
General Counsel bei IPI LEGACY LIQUIDATION CO
Profil
Lynn Gold is currently the Senior Vice President-Regulatory Affairs at Impel Pharmaceuticals, Inc. Prior to this, she worked as the Vice President-Research & Process Development at Sonus Pharmaceuticals, Inc. and as the Vice President-CMC Services at Camargo Pharmaceutical Services LLC.
Dr. Gold holds a doctorate degree from the University of Rochester and an undergraduate degree from the State University of New York at Buffalo.
Aktive Positionen von Lynn Gold
| Unternehmen | Position | Beginn |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | General Counsel | 01.07.2018 |
Ehemalige bekannte Positionen von Lynn Gold
| Unternehmen | Position | Ende |
|---|---|---|
Camargo Pharmaceutical Services LLC
 Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | 01.06.2010 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Lynn Gold
| Rochester Christian University | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Commercial Services |
